Revitope Oncology
Manufacturing · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
700 Main St, Cambridge, Massachusetts, 0...Phone Number
(617) 500-0365Website
www.revitope.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
2
1
1
1
1
About Revitope Oncology
Revitope Oncology Inc. is a biotechnology company focused on developing a new class of precision cancer immunotherapies through advanced protein engineering and biological insights. Their proprietary GATE Technology Platform enables the design of bispecific antibodies that specifically target tumor cells while minimizing toxicity to healthy tissues. The company aims to address unmet needs in solid tumors by eliciting powerful immune responses directed exclusively at cancer cells. Revitope's innovative approach is designed to improve therapeutic efficacy and safety, making it a promising player in the field of cancer treatment.Explore more
Revitope Oncology Org Chart
AW
Research Associate II
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Revitope Oncology your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Revitope Oncology is spiking on competitors!
Earning: See what the market has to say on Revitope Oncology recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Revitope Oncology launches new products
Website visits: Recent activity has been detected on your website
Click to see if Revitope Oncology had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Revitope Oncology has new funding data
Congratulate Masked Content for being promoted to Masked Content at Revitope Oncology
Check if Revitope Oncology has recently received funding, and reach out quickly before it becomes old news!
Revitope Oncology, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Revitope Oncology
Compare insights from companies similar to Revitope Oncology, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$6.5M
11-50
Public
$340.5M
2015
KB
Kristi BalacyHead Senior Director, Clinical Development Operations & of Clinical Operations
Company Profile Activity
Activity Insights
Revitope Oncology is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Revitope Oncology is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Revitope Oncology.
Revitope Oncology Tech Stack
A closer look at the technologies used by Revitope Oncology
See more technologies
Revitope Oncology News & Media
Applied BioMath, LLC Announces that Revitope Oncology is extending its Collaboration on Systems Pharmacology Modeling in Solid Tumors
CONCORD, Mass., Feb. 9, 2021 /PRNewswire/ -- Applied BioMath (www.appliedbiomath.com), the industry-leader in applying systems pharmacology and mechanistic modeling, simulation, and analysis to de-risk drug research and development, today announced that Revitope Oncology is extending its...Revitope Oncology Appoints Biotech Industry Pioneer Louis Lange to its Board of Directors
CAMBRIDGE, Mass., Feb. 2, 2021 /PRNewswire/ -- Revitope Oncology, Inc., a biotechnology company advancing a new class of precision cancer immunotherapies, today announced the appointment of biotechnology pioneer Louis Lange, M.D., Ph.D., to its Board of Directors. "We are pleased to...Revitope Oncology Announces Strategic Collaboration with Janssen to Leverage its Unique T Cell Engager Platform
CAMBRIDGE, Mass., Jan. 5, 2021 /PRNewswire/ -- Revitope Oncology Inc. (Revitope), a biotechnology company advancing a new class of precision cancer immunotherapies, today announced that the company has entered into a collaboration with Janssen Biotech, Inc. ("Janssen"), one of the Janssen...Revitope Oncology Adds Carsten Reinhardt, a Pioneer of Modern Immunotherapy, to its Board of Directors
CAMBRIDGE, Mass., Sept. 16, 2020 /PRNewswire/ -- Revitope Oncology, Inc., a biotechnology company advancing a new class of precision cancer immunotherapies today announced the appointment of life sciences industry veteran Carsten Reinhardt, M.D., Ph.D., to its Board of Directors. Dr....
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Revitope Oncology
Sign Up For FreeTo access detailed company insights
Revitope Oncology Inc. is a biotechnology company focused on developing a new class of precision cancer immunotherapies through advanced protein engineering and biological insights. Their proprietary GATE Technology Platform enables the design of bispecific antibodies that specifically target tumor cells while minimizing toxicity to healthy tissues... Read More
